Clinical Trial Update: Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis [NA]

View source ↗

Summary

A clinical trial is evaluating fecal noninvasive biomarkers oriented control versus usual care for ulcerative colitis, and it is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Noninvasive Biomarkers, Ulcerative Colitis (UC) | NA | Status: NOT_YET_RECRUITING